$CYCC
Cyclacel Pharmaceuticals, Inc.

2023 Q4 Form 10-Q Financial Statement

#000155837023019370 Filed on November 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $31.00K $16.00K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.873M $1.625M
YoY Change -12.6% -20.89%
% of Gross Profit
Research & Development $3.518M $5.236M
YoY Change -47.51% 18.65%
% of Gross Profit
Depreciation & Amortization $8.000K $3.000K
YoY Change 0.0% -57.14%
% of Gross Profit
Operating Expenses $5.391M $6.861M
YoY Change -39.05% 6.09%
Operating Profit -$6.845M
YoY Change 5.85%
Interest Expense -$333.0K $154.0K
YoY Change 109.43% -55.1%
% of Operating Profit
Other Income/Expense, Net $0.00 $145.0K
YoY Change -100.0% -59.38%
Pretax Income -$5.693M -$6.700M
YoY Change -36.74% 9.66%
Income Tax -$422.0K -$668.0K
% Of Pretax Income
Net Earnings -$5.321M -$6.032M
YoY Change -28.76% 18.37%
Net Earnings / Revenue -17164.52% -37700.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.23 -$7.20
COMMON SHARES
Basic Shares Outstanding 12.64M 12.64M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.378M $5.944M
YoY Change -81.59% -74.93%
Cash & Equivalents $3.378M $5.900M
Short-Term Investments
Other Short-Term Assets $341.0K $1.950M
YoY Change -19.95% 1047.06%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.444M $11.11M
YoY Change -69.51% -60.19%
LONG-TERM ASSETS
Property, Plant & Equipment $9.000K $16.00K
YoY Change -71.88% -56.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.259M $1.259M
YoY Change -56.82% -56.82%
Total Long-Term Assets $1.361M $1.384M
YoY Change -55.95% -55.44%
TOTAL ASSETS
Total Short-Term Assets $7.444M $11.11M
Total Long-Term Assets $1.361M $1.384M
Total Assets $8.805M $12.50M
YoY Change -67.98% -59.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.543M $1.571M
YoY Change 38.34% 59.82%
Accrued Expenses $4.618M $6.577M
YoY Change -4.41% 95.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.161M $8.148M
YoY Change 10.4% 87.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $37.00K $52.00K
YoY Change -65.09% -51.4%
Total Long-Term Liabilities $37.00K $52.00K
YoY Change -65.09% -51.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.161M $8.148M
Total Long-Term Liabilities $37.00K $52.00K
Total Liabilities $8.198M $8.200M
YoY Change 9.34% 83.86%
SHAREHOLDERS EQUITY
Retained Earnings -$428.3M -$423.0M
YoY Change 5.44% 6.09%
Common Stock $1.000K $12.00K
YoY Change -88.89% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $607.0K $4.297M
YoY Change
Total Liabilities & Shareholders Equity $8.805M $12.50M
YoY Change -67.98% -59.71%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.321M -$6.032M
YoY Change -28.76% 18.37%
Depreciation, Depletion And Amortization $8.000K $3.000K
YoY Change 0.0% -57.14%
Cash From Operating Activities -$3.910M -$4.032M
YoY Change -24.36% -42.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $4.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 999.0K -51.00K
YoY Change 2278.57% -103.33%
NET CHANGE
Cash From Operating Activities -3.910M -4.032M
Cash From Investing Activities 0.000 4.000K
Cash From Financing Activities 999.0K -51.00K
Net Change In Cash -2.911M -4.079M
YoY Change -43.22% -24.96%
FREE CASH FLOW
Cash From Operating Activities -$3.910M -$4.032M
Capital Expenditures $0.00 -$4.000K
Free Cash Flow -$3.910M -$4.028M
YoY Change -24.36% -42.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1259000
dei Entity Central Index Key
EntityCentralIndexKey
0001130166
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Cyclacel Pharmaceuticals, Inc.
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
3117100
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12642822
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9422089
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50626
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1707622
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Connell Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1500
dei Entity Address City Or Town
EntityAddressCityOrTown
Berkeley Heights
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07922
dei City Area Code
CityAreaCode
908
dei Local Phone Number
LocalPhoneNumber
517-7330
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12642822
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5944000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18345000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5169000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6066000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
11113000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
24411000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
109000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
142000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3465000
CY2023Q3 us-gaap Assets
Assets
12497000
CY2022Q4 us-gaap Assets
Assets
28050000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1571000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2561000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6577000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4950000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8148000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7511000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106000
CY2023Q3 us-gaap Liabilities
Liabilities
8200000
CY2022Q4 us-gaap Liabilities
Liabilities
7617000
CY2023Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
3117100
CY2023Q3 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
4494000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12642822
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9422089
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
428464000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
422973000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1168000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1316000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-423011000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-405727000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4297000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15939000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12497000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28050000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
389000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5236000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4413000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15637000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13572000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1625000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2054000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4845000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5239000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6861000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6467000
us-gaap Operating Expenses
OperatingExpenses
20482000
us-gaap Operating Expenses
OperatingExpenses
18811000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6845000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6467000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20093000
us-gaap Operating Income Loss
OperatingIncomeLoss
-18811000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
104000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
276000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-58000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
514000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
67000
us-gaap Investment Income Interest
InvestmentIncomeInterest
243000
us-gaap Investment Income Interest
InvestmentIncomeInterest
88000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1294000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
357000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
235000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1896000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6700000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6110000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19858000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16915000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-668000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1014000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2574000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3136000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6032000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096000
us-gaap Net Income Loss
NetIncomeLoss
-17284000
us-gaap Net Income Loss
NetIncomeLoss
-13779000
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
151000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
151000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6082000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5146000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17435000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13930000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6032000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096000
us-gaap Net Income Loss
NetIncomeLoss
-17284000
us-gaap Net Income Loss
NetIncomeLoss
-13779000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8571000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17874000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2050000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
39392000
CY2023Q3 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-8642000
CY2022Q3 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-18344000
cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
2198000
cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-40390000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6103000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5566000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17136000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14777000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
37693000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
380000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2022Q1 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-5878000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5803000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4108000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33840000
CY2022Q2 cycc Stock Issued During Period Value At Market Issuance Sales Agreement
StockIssuedDuringPeriodValueAtMarketIssuanceSalesAgreement
453000
CY2022Q2 cycc Adjustments To Additional Paid In Capital Deemed Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDeemedDividendsInExcessOfRetainedEarnings
33000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
350000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2022Q2 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-16168000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15715000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4575000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
29532000
CY2022Q3 cycc Increase In Carrying Amount Of Redeemable Common Stock
IncreaseInCarryingAmountOfRedeemableCommonStock
1705000
CY2022Q3 cycc Adjustments To Additional Paid In Capital Deemed Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDeemedDividendsInExcessOfRetainedEarnings
102000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
388000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2022Q3 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-18344000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17874000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
22497000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15939000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
401000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2023Q1 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
5263000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5171000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5804000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10578000
CY2023Q2 cycc Increase In Carrying Amount Of Redeemable Common Stock
IncreaseInCarryingAmountOfRedeemableCommonStock
-1105000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
359000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2023Q2 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
5577000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5450000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5448000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6671000
CY2023Q3 cycc Increase In Carrying Amount Of Redeemable Common Stock
IncreaseInCarryingAmountOfRedeemableCommonStock
-3389000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
390000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
50000
CY2023Q3 cycc Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax
OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTax
-8642000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8571000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6032000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4297000
us-gaap Net Income Loss
NetIncomeLoss
-17284000
us-gaap Net Income Loss
NetIncomeLoss
-13779000
us-gaap Depreciation
Depreciation
23000
us-gaap Depreciation
Depreciation
24000
us-gaap Share Based Compensation
ShareBasedCompensation
1151000
us-gaap Share Based Compensation
ShareBasedCompensation
1119000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-55000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
29000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3364000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2816000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
599000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-235000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12202000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15658000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7000
cycc Proceeds From Issuance Of Common Stock And Warrant Exercises Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantExercisesNetOfIssuanceCosts
0
cycc Proceeds From Issuance Of Common Stock And Warrant Exercises Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantExercisesNetOfIssuanceCosts
3107000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
151000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
151000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-151000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2956000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-42000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-144000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12401000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12853000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18345000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36559000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5944000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23706000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
243000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
89000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
4846000
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
3050000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
cycc Accrual Of Preferred Stock Dividends
AccrualOfPreferredStockDividends
50000
cycc Accrual Of Preferred Stock Dividends
AccrualOfPreferredStockDividends
50000
cycc Deemed Dividend On Redeemable Common Stock
DeemedDividendOnRedeemableCommonStock
0
cycc Deemed Dividend On Redeemable Common Stock
DeemedDividendOnRedeemableCommonStock
135000
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3465000
CY2023Q1 us-gaap Assets
Assets
22609000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4948000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7457000
CY2023Q1 us-gaap Liabilities
Liabilities
7537000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-411531000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10578000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22609000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5854000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10578000
CY2023Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1549000
CY2023Q2 us-gaap Assets
Assets
16991000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4696000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6865000
CY2023Q2 us-gaap Liabilities
Liabilities
6931000
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
3389000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
424737000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-416979000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6671000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16991000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5498000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11353000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10578000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5900000
CY2024Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3100000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
389000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5804000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5854000
CY2023Q1 cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-5854000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5448000
us-gaap Net Income Loss
NetIncomeLoss
-11252000
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
101000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5498000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11353000
CY2023Q2 cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-5498000
cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-11353000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6032000
us-gaap Net Income Loss
NetIncomeLoss
-17284000
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
151000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6082000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17435000
CY2023Q3 cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-6082000
cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-17435000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096000
us-gaap Net Income Loss
NetIncomeLoss
-13779000
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
50000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
151000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5146000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13930000
CY2022Q3 cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-5248000
cycc Undistributed Net Income Loss Available To Common Stockholders Diluted
UndistributedNetIncomeLossAvailableToCommonStockholdersDiluted
-14065000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7133449
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6185535
CY2023Q3 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
2527000
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
4664000
CY2023Q3 cycc Prepayments And Value Added Tax Receivable Current
PrepaymentsAndValueAddedTaxReceivableCurrent
692000
CY2022Q4 cycc Prepayments And Value Added Tax Receivable Current
PrepaymentsAndValueAddedTaxReceivableCurrent
976000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1950000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
426000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5169000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6066000
CY2023Q3 cycc Deposits Held By Related Party Current
DepositsHeldByRelatedPartyCurrent
1600000
CY2023Q3 cycc Deposits Held By Related Party
DepositsHeldByRelatedParty
1300000
CY2023Q3 cycc Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
5866000
CY2022Q4 cycc Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3611000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
355000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
333000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
356000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1006000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6577000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4950000
us-gaap Operating Lease Expense
OperatingLeaseExpense
55982
us-gaap Operating Lease Expense
OperatingLeaseExpense
46699
us-gaap Operating Lease Payments
OperatingLeasePayments
55245
us-gaap Operating Lease Payments
OperatingLeasePayments
46489
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
19000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
66000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
38000
CY2023Q3 cycc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
0
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
123000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
390000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
389000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1151000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1119000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0

Files In Submission

Name View Source Status
cycc-20230930_cal.xml Edgar Link unprocessable
cycc-20230930_lab.xml Edgar Link unprocessable
cycc-20230930_pre.xml Edgar Link unprocessable
0001558370-23-019370-index-headers.html Edgar Link pending
0001558370-23-019370-index.html Edgar Link pending
0001558370-23-019370.txt Edgar Link pending
0001558370-23-019370-xbrl.zip Edgar Link pending
cycc-20230930.xsd Edgar Link pending
cycc-20230930x10q.htm Edgar Link pending
cycc-20230930xex31d1.htm Edgar Link pending
cycc-20230930xex31d2.htm Edgar Link pending
cycc-20230930xex32d1.htm Edgar Link pending
cycc-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cycc-20230930_def.xml Edgar Link unprocessable
cycc-20230930x10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending